Grafton Sciences

Grafton Biosciences is a biotechnology startup based in South San Francisco. The company focuses on developing innovative solutions to address diseases by integrating computation, hardware, and advanced biology. Grafton aims to make biology computable through a closed-loop system that targets various diseases, particularly in the field of early cancer detection. The company specializes in early disease detection, diagnostics, and therapeutics. It employs advanced techniques such as multi-omics sensing and at-home diagnostic capabilities to enhance the accuracy of disease identification. Grafton utilizes computational chemistry and molecular modeling to design and optimize its solutions, closely linking computational work with experimental biology to accelerate discovery and development. With $40 million in funding, Grafton Biosciences is building a team of skilled engineers and scientists to support its mission of extending healthy human lifespans and driving health innovations.